ForeSENTIA is an extensive portfolio of tumor profile panels that identify genetic alterations (changes) implicated in cancer. The ForeSENTIA panels test for alterations on genes that have important roles in cancer. Identifying these genetic alterations is beneficial for:
- providing an in-depth understanding of the molecular profile to the healthcare provider
- giving a better prognostic assessment
- allowing for more precise and effective medical recommendations
- improving clinical management and patient outcome
- guiding therapy options
ForeSENTIA has 2 panel categories – depending on your cancer type and its characteristics, your doctor will recommend the best panel for you.
COMPREHENSIVE TUMOR PROFILE PANELS
ForeSENTIA comprehensive tumor profile panels focus on a number of genetic changes found in specific cancer types.
-
BREAST / OVARIAN
44
-
COLORECTAL
33
-
LUNG (NSCLC)
35
-
PROSTATE
27
-
MELANOMA
21
-
GLIOMA
22*
-
PAN-CANCER
76*
* 1p/19q codeletion is also tested in these panels and reported only in the context of glioma diagnosis.
BREAST/OVARIAN TUMOR PROFILE PANEL
Description
The ForeSENTIA breast/ovarian tumor profile panel tests for numerous genetic alterations that are frequently found in gynecological tumors. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with breast or ovarian cancer can have tumor profile testing with the ForeSENTIA breast/ovarian panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
44
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA beast/ovarian tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Breast/Ovarian Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, ATM, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CHEK2, CTNNB1, DICER1, EGFR, ERBB2, ERBB3, ESR1, FBXW7, FOXA1, FOXL2, GATA3, KIT, KRAS, MAP3K1, MRE11A, MTOR, NBN, NRAS, PALB2, PIK3CA, PIK3CB, POLE, PTEN, RAD51C, RAD51D, RAF1, RET, RUNX1, SMAD4, TP53 | EGFR, ERBB2, ESR1, FGFR1, FGFR2, FGFR3, KRAS, MET, PIK3CA, PTEN, TP53 | NTRK1, NTRK2, NTRK3 |
COLORECTAL TUMOR PROFILE PANEL
Description
The ForeSENTIA colorectal tumor profile panel tests for numerous genetic alterations that are frequently found in colorectal tumors. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with colorectal cancer can have tumor profile testing with the ForeSENTIA colorectal cancer panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
33
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA colorectal tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Colorectal Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, APC, ATM, BRAF, BRCA1, BRCA2, CTNNB1, EGFR, ERBB2, FBXW7, GNAS, KRAS, MLH1, MSH2, MSH6, MTOR, NRAS, NTRK1, PALB2, PIK3CA, PIK3CB, PMS2, POLE, PTEN, RAF1, SMAD4, TP53 | EGFR, ERBB2, FGFR1, FGFR2, FGFR3, KRAS, MET, TP53 | NTRK1, NTRK2, NTRK3 |
LUNG (NSCLC) TUMOR PROFILE PANEL
Description
The ForeSENTIA lung (NSCLC) tumor profile panel tests for numerous genetic alterations that are frequently found in lung (Non Small Cell Lung Cancers – NSCLC) tumors. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with lung (NSCLC) cancer can have tumor profile testing with the ForeSENTIA lung (NSCLC) panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
35
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA lung (NSCLC) tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Lung (NSCLC) Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, ALK, APC, ARAF, ATM,BRAF, BRCA2, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, FBXW7, JAK2, KEAP1, KRAS, MAP2K1, MET, NRAS, PIK3CA, POLE, PTEN, RAF1, SMAD4, STK11, TP53 | EGFR, ERBB2, FGFR1, FGFR2, FGFR3, MET, PIK3CA, PTEN, TP53 | ALK, FGFR3, NTRK1, NTRK2, NTRK3, RET, ROS1 |
MELANOMA TUMOR PROFILE PANEL
Description
The ForeSENTIA melanoma tumor profile panel tests for numerous genetic alterations that are frequently found in melanomas. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with melanoma cancer can have tumor profile testing with the ForeSENTIA melanoma panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
21
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA melanoma tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Prostate Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, BRAF, CTNBB1, ERBB2, GNA11, GNAQ, KIT, KRAS, MAP2K1, NF1, NRAS, PIK3CA, POLE, PTEN, TP53 | ERBB2, KIT, KRAS, MYC, TP53 | ALK, BRAF, NTRK1, NTRK2, NTRK3, RET, ROS1 |
PROSTATE TUMOR PROFILE PANEL
Description
The ForeSENTIA prostate tumor profile panel tests for numerous genetic alterations that are frequently found in prostate tumors. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with prostate cancer can have tumor profile testing with the ForeSENTIA prostate panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
27
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA prostate tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Prostate Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, APC, AR, ATM, BRAF, BRCA1, BRCA2, CTNNB1, CHEK2, FOXA1, NRAS, PALB2, PIK3CA, PIK3CB, POLE, PTEN, RAD51D, SPOP, TP53 | AR, ERBB2, FGFR1, FGFR2, FGFR3, MYC, MYCN, PIK3CA, PTEN, RB1, TP53 | TMPRSS2 |
GLIOMA TUMOR PROFILE PANEL
Description
The ForeSENTIA glioma tumor profile panel tests for numerous genetic alterations that are frequently found in gliomas. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with glioma cancer can have tumor profile testing with the ForeSENTIA glioma panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
22
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA glioma tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Glioma Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| ATRX, BRAF, CIC, CTNNB1, EGFR, FUBP1, H3F3A, IDH1, IDH2, NF1, POLE, TERT, TP53 | 1p/19q codeletion, CDKN2A, EGFR, MET, MYC, MYCN, PTEN | BRAF, FGFR3, NF1, NTRK1, NTRK2, NTRK3 |
PAN-CANCER TUMOR PROFILE PANEL
Description
The ForeSENTIA pan-cancer tumor profile panel tests for numerous genetic alterations that are frequently found in several cancers. Identifying the genetic alterations that have led to cancer development can empower the healthcare provider with clinically actionable and therapeutic information and allow them to tailor medical treatment to each tumor’s unique characteristics.
Who is this test for?
Any patient diagnosed with cancer can have tumor profile testing with the ForeSENTIA pan-cancer panel to help identify the specific genetic alterations that are associated with their tumor.
Number Of Genes Tested
76
Sample: Unstained sections from tumor biopsy sample
Turnaround time: 2-3 Weeks
Genes Tested
The table below shows the genes tested by the ForeSENTIA pan-cancer tumor profile panel, and whether the genes examined are tested for Single Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, Translocations or a combination of variants.
ForeSENTIA Pan-Cancer Tumor Profile Panel
| Single Nucleotide Variants / Insertions and Deletions | Copy Number Alterations | Translocations |
|---|---|---|
| AKT1, ALK, APC, AR, ARAF, ATM, ATRX, BARD1, BRAF, BRCA1,BRCA2, BRIP1, CHEK2, CIC, CTNNB1,DDR2, DICER1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FBXW7, FOXA1, FOXL2, FUBP1, GATA3,GNA11, GNAQ, GNAS, H3F3A, IDH1, IDH2, JAK2, KEAP1, KIT, KRAS, MAP2K1, MAP3K1, MET, MLH1, MRE11A, MSH2, MSH6, MTOR, NBN, NF1, NRAS, NTRK1, PALB2, PIK3CA, PIK3CB, PMS2, POLE, PTEN, RAD51C, RAD51D, RAF1, RET, RUNX1, SMAD4, SPOP, STK11, TERT, TP53 | 1p/19q codeletion, AR, CDKN2A, EGFR, ERBB2, ESR1, FGFR1, FGFR2, FGFR3, KIT, KRAS, MET, MYC, MYCN, PIK3CA, PTEN, RB1, TP53 | ALK, BRAF, FGFR3, NF1, NTRK1, NTRK2, NTRK3, RET, ROS1, TMPRSS2 |
THERAPY-ASSOCIATED TUMOR PROFILE PANELS
ForeSENTIA therapy-associated tumor profile panels focus on genes that are frequently involved in several cancer types.
EGFR KRAS+NRAS PIK3CA+AKT1 BRAF IDH1 + IDH2
Approved targeted therapies or ongoing clinical trials are available to treat specific cancer types caused by alterations in these genes.
HOW DO CANCER MUTATIONS DEVELOP?
Mutations (alterations) in our genes can happen in two ways: either we were born with them by inheriting them from our parents (hereditary), or we acquired them during our lives (somatic).
Somatic mutations can develop due to many risk factors such as smoking, high alcohol consumption, viruses such as HPV (human papillomavirus), exposure to mutagenic chemicals, and environmental pollutants. These alterations cannot be passed to our children. It could take years or decades for them to develop into cancer, depending on the mutations and the site they occur in.
KNOW YOUR GENES, KNOW YOUR CHOICES
When it comes to cancer, don’t rely on general statistical data and standardized treatment.
ForeSENTIA can potentially identify the genetic alterations (changes) that led to your tumor, providing useful information to your doctor in guiding your treatment
HOW DOES ForeSENTIA HELP ME?
ForeSENTIA identifies the characteristics that make your tumor unique. By finding the specific alterations involved in the tumor, your treatment could become precise and targeted – raising your chances of benefiting from your therapy.
With ForeSENTIA, your doctor will have reliable and detailed information of your tumor, allowing them to choose the most suitable treatment options, drug therapies and possibly even clinical trials for you, improving your clinical care.
WHY CHOOSE ForeSENTIA?
- Eligibility for targeted therapies
- Higher chances of successful treatment
- Improved prognostic insight
- Better clinical management
- Short turn-around time
- Proven technology
HOW IS ForeSENTIA PERFORMED?
ForeSENTIA uses a sample from the tumor biopsy that has already been performed.
TECHNOLOGY YOU TRUST
TARGETED TECHNOLOGY
By focusing only on the genetic alterations tested, ForeSENTIA is accurate and precise.
HIGH READ DEPTH
ForeSENTIA analyzes the locations of the genetic alterations hundreds of times, making the test more sensitive and reliable.
HOW IS ForeSENTIA ADMINISTERED ?
-
TALK TO YOUR DOCTOR ABOUT THE IDEAL PANEL FOR YOU
A SAMPLE FROM YOUR TUMOR
BIOPSY WILL BE SENT TO US
THE SAMPLE WILL BE ANALYZED
IN OUR LABORATORY
RESULTS WILL BE SENT TO YOUR DOCTOR IN 2-3 WEEKS
Depending on the panel, guidance on finding information on therapy choices and clinical trials will be provided.
FAQ
-
What is genetic testing?
Genetic testing identifies changes in the DNA. These changes might determine the health of an individual.
-
What are somatic mutations?
Somatic mutations, or alterations, are genetic changes in the DNA that happen after a person is born. These are acquired during a person’s lifetime due to risk factors like smoking, high alcohol consumption and environmental pollutants, and are not inherited. People with cancer have cancer-related somatic alterations in the tumor.
-
What is a tumor profile testing and why is it useful?
The same cancer type can be caused by different genetic alterations. These differences in the genetic profile of tumors account for the variability of symptoms, progress of disease and response to treatment. Tumor profile testing identifies the specific genetic alteration responsible for cancer development in each patient. The information gained by tumor profile testing allows for a more accurate and reliable prognosis, and helps the healthcare provider choose the most appropriate treatment for their patients depending on the tumor’s unique genetic characteristics.
-
Who should have tumor profile testing?
Any patient diagnosed with cancer can have tumor profile testing to help identify the specific genetic alterations that are associated with it. This information is critical for healthcare providers as it empowers them to provide a more precise clinical management and treatment that is tailored to the patient’s tumor profile and as such has better chances of being beneficial.
-
How can the ForeSENTIA tumor profile panels help?
The ForeSENTIA tumor profile panels give you the option to analyze a comprehensive list of genetic alterations found in tumor, allowing for the best chance to identify the genetic alterations that caused the cancer. This information will allow the healthcare provider to choose a treatment plan that is expertly fitted to the characteristics of the tumor, identify relevant clinical trials and approved therapies, thus providing the patient with improved prognostic insight and medical management.
Other Products
NIPD Genetics - Privacy Policy
General Statement
NIPD Genetics is a leading, innovative biotechnology company that designs, develops, and provides a broad spectrum of healthcare services to its customers through its expansive portfolio of molecular and clinical laboratory tests in all disciplines.
At NIPD Genetics we are committed to protecting and respecting our customer’s privacy and personal information. Personal information or personal data means any information that identifies, relates to, describes, is capable of being associated with, or could be reasonably linked, directly or indirectly, with a particular individual, such as name, identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that individual.
NIPD Genetics collects and processes your personal information according to the General Data Protection Regulation (EU) 2016/679 and the Cypriot law providing for the protection of natural persons with regards to the processing of personal data and for the free movement of such data (L. 125(I)/2018). The following principles lie at the heart of our approach to handling personal data:
- Lawfulness, fairness and transparency – We collect and process personal data in a lawful and transparent manner and clearly communicate to our customers how their personal data will be used.
- Purpose limitation – We only use personal data for the purpose for which they have been collected.
- Data minimization – We only collect the data that is absolutely necessary in relation to the purposes for which they are processed.
- Accuracy – We take every reasonable step to ensure that personal data collected are accurate and up to date.
- Storage limitation – We do not keep personal data for longer than it is needed. Personal data are periodically reviewed and erased if they are not needed or anonymized and stored for scientific research purposes.
- Integrity and confidentiality (security) – Appropriate technical and organizational measures are in place to ensure that personal data are adequately protected from any unauthorised or illegal processing and accidental loss, destruction or damage.
- Accountability – We, at NIPD Genetics, are committed to compliance with all legal requirements and promote internal practices to achieve the highest standards for personal data privacy.
NIPD Genetics has appointed a Data Protection Officer (DPO) who is responsible for overseeing and ensuring that personal information is collected and processed in line with these principles. The contact details of the Data Protection Officer (DPO) can be found below:
Email address: dpo@nipd.com
Postal address: 31 Neas Engomis street, 2409 Engomi, Nicosia, Cyprus
Telephone number: + 357 22266888
By accessing or using our products or services, or by transmitting information to us by email or other electronic means, you accept our policies, procedures and practices described in this Privacy Policy. If you do not agree with our policies, procedures and practices as described, you can choose not to access or use our products or services or not to transmit personal information to us.
This Privacy Policy applies to NIPD Genetics facilities, its websites www.nipd.com, www.nipdlabs.com, www.nipdlabs.com.cy and their subdomains, that link to this privacy pol icy.
PERSONAL INFORMATION COLLECTION AND PROCESSING
We collect and process several types of personal information from and about users of our websites and of our products and services, including:
- Personal and sensitive information: some of our products and services may involve testing of biological samples that we or our customers use to create test reports, genotyping or sequencing services for research or clinical purposes and the receipt, creation, or analysis of genomic or other data derived from samples, including through our customer’s use of our software as a service product. In receiving samples and providing our products and services, we may obtain your name and surname, date of birth, email address, home address, telephone number, gender, ethnicity and other health related information.
- Computer, device and browsing information: as you interact with our products and services online, including this website, we may use automatic data collection technologies to collect certain information about your computer or device, as well as browsing actions and usage patterns. This data may include your IP address, browser type or version. The technologies we use for this automatic data collection may include cookies. You can control cookies by adjusting your cookies settings.
Information about children
If you are under 18 years of age, do not register on our website or provide any information about yourself to us. We do not provide our products or services directly to children or proactively collect their personal information. Despite this prohibition, it is possible that we may sometimes be given information about children while handling samples from our customers in our clinical labs, or through use of our products and services by our customers and partners. If we become aware that we have inadvertently collected personal information from children under the age of 18, without parental consent, we will take the necessary steps to delete it as soon as possible in compliance with applicable laws.
LEGAL BASIS FOR PROCESSING OF YOUR PERSONAL INFORMATION
Your personal information is collected by NIPD Genetics for the following purposes:
- To provide you with our products and services, respond to your inquiries or fulfill your requests and otherwise manage your relationship with us. The legal basis for processing is to meet the requirements of a contract, to comply with our legal obligations and/or because we have a legitimate interest in responding to requests for information about our products and services.
- To communicate with you about content and product offerings, newsletters and event invitations which are relevant to your interests and in line with your preferences. The legal basis for processing is the individual’s explicit consent prior to sending the information and managing individuals preferences.
- To process and respond to complaints. The legal basis for processing is to meet a legal obligation.
- To monitor and record information relating to the use of our products and services, including our website. The legal basis for processing is our legitimate interest in order to improve our products and services and our website for individuals.
To provide our products and services, NIPD Genetics may collect, receive and process biological samples to isolate and sequence DNA. NIPD Genetics may then store resulting genetic information and use genetic information to provide our products and services. In some cases, NIPD Genetics may provide interpretations of genetic information on behalf of its customers, including healthcare providers. This is only done pursuant to a written contract or a Sample Information Form with a patient’s informed consent and is subject to applicable legal and ethical safeguards.
This sensitive information described above is collected by NIPD Genetics for the following purposes:
- To provide support and maintenance services to customers who use our products and services – The legal basis for processing is to meet the requirements of a contract.
- To provide genotyping and sequencing services and analysis for our customers, including healthcare providers. The legal basis of this processing is to meet the requirements of a contract or as allowed in the Sample Information Form with a patient’s informed consent.
- To conduct genotyping and sequencing services and analysis for quality control, process and product development and improvements, and optimization in our labs to reflect quality improvements and advances in our technology. The legal basis for processing is the patient’s informed consent given through the Sample Information Form.
Transfer of Data
Your information, including personal data, may be transferred to - and maintained on - computers located outside your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.
If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.
Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.
NIPD Genetics will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal information will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.
Disclosure of Data
NIPD Genetics complies with the General Data Protection Regulation and will not sell or trade your personal information.
NIPD Genetics may disclose your personal information in the good faith that such action is necessary:
- To comply with a legal obligation
- To protect and defend the rights or property of NIPD Genetics
- To prevent or investigate possible wrongdoing in connection with our products and services
- To protect against legal liability
COOKIES AND OTHER TRACKING TECHNOLOGIES
Cookies are files with small amount of data which may include an anonymous unique identifiers. Cookies are sent to your browser when you visit a website and stored on your device. Tracking technologies used on the website are beacons, tags and scripts, to collect and track information and to improve and analyze our websites.
We use cookies and similar tracking technologies to track the activity on our websites and collect certain information. This includes information about the computer or device you are using, such as Internet protocol (IP) address, information about the browser type or version, the pages of our website that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.
You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our websites.
Examples of Cookies we may use:
Session Cookies. We use Session Cookies to operate our websites.
Preference Cookies. We use Preference Cookies to remember your preferences and various settings.
Security Cookies. We use Security Cookies for security purposes.
Visitor behavior cookies. To understand how visitors use and navigate the websites
Keyword cookies. To understand how visitors discover the websites.
ANALYTICS
We may use third-party Service Providers to monitor and analyze the use of our websites.
Google Analytics
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.
You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.
For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page
SECURITY OF DATA
We are committed to protecting the security of the information we collect, and we take reasonable physical, technical, and administrative safeguards such as data anonymization and encryption to help protect personal information from unauthorized or inappropriate access or use. It is your responsibility to protect the confidentiality of your passwords, and any other access features associated with your access or use of the website or our products and services, as well as to adhere to any applicable Terms of Use or other contract between us and you or your organization.
PERSONAL DATA RETENTION
We may retain collected information even after you remove it from the website, our Services, or our Products, to comply with applicable law, to resolve disputes, to enforce any rights in connection with the website, our Services, or our Products, and to use as provided in this Privacy Policy, the Terms of Use, or an applicable contract between us and you or your organization. How long we retain specific personal information varies depending on the purpose for its use and we may delete or retain your personal information in accordance with applicable law.
SERVICE PROVIDERS
We may employ third party companies and individuals to facilitate, maintain or operate our websites (“Service Providers”), to provide the websites on our behalf, to perform service-related services or to assist us in analyzing how our websites are used.
These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.
LINKS TO OTHER SITES
Our websites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.
We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.
CHANGES TO THIS PRIVACY POLICY
This Privacy Policy may be updated from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.
We will let you know via email and/or a prominent notice on our website, prior to the change becoming effective and update the “effective date” at the bottom of this Privacy Policy.
You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.
YOUR LEGAL RIGHTS
NIPD Genetics ensures that it can respond immediately to requests that you make for the exercise of your legal rights in accordance with data protection laws. These rights are as follows:
- The right to withdraw consent at any time – in cases where processing is based on your consent
- The right of access – at any given time you have the right to know what information about you we hold and receive information about the processing activities we perform
- The right to rectify – you have the right to correct, amend and complete personal data that is incomplete
- The right to erasure (“right to be forgotten”) – you can request that your personal information is deleted
- The right to object – you can object at any time to our processing of your personal information
- The right to restriction of processing – this applies in the event:
- You dispute the accuracy of your personal information and until it is verified
- You oppose to the deletion of personal data and ask instead to delete the use of it
- The personal information is no longer necessary for us
- You object to the processing and we are considering whether our legitimate grounds for processing prevail over the reasons you oppose to the processing
- The right to data portability – at any given time you have the right to receive the personal information we hold about you in a structured, commonly used and machine-readable format (pdf, word etc.). You also have the right to request that these data are transferred to another service in a safe and secure way
You also have the right to lodge a complaint at any time to the Office of the Commissioner for Personal Data Protection.
We encourage you to contact us, should you wish to practice any of your legal rights or you have any questions about this Privacy Policy, by sending an email to NIPD Genetics’ Data Protection Officer at dpo@nipd.com.
Effective date: 18/06/2021
Ok got it!